» Articles » PMID: 3627286

Ketoconazole Impairs Biliary Excretory Function in the Isolated Perfused Rat Liver

Overview
Specialty Pharmacology
Date 1987 Jun 1
PMID 3627286
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of ketoconazole (KT) on the hepatic excretory function was investigated in the isolated perfused rat liver. KT, at the concentrations of 5 X 10(-5) M or 10(-4) M caused dose-dependent decreases of the biliary bile acid concentration and excretion rate, with no significant effect on bile flow rates. Neither dose altered perfusate flow through the liver. Furthermore, at the same two concentrations, KT impaired the sulfobromophthalein transport in a dose-dependent manner. In contrast, the drug did not alter 14C-sucrose bile to perfusate ratio and did not cause enzyme release from the liver into the perfusate. The study demonstrates that KT possesses an intrinsic toxicity in the isolated perfused rat liver and suggests caution in the use of this drug in hepatopathic patients.

References
1.
Lake J, LICKO V, Van Dyke R, Scharschmidt B . Biliary secretion of fluid-phase markers by the isolated perfused rat liver. Role of transcellular vesicular transport. J Clin Invest. 1985; 76(2):676-84. PMC: 423875. DOI: 10.1172/JCI112021. View

2.
Petersen E, Alling D, Kirkpatrick C . Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. Ann Intern Med. 1980; 93(6):791-5. DOI: 10.7326/0003-4819-93-6-791. View

3.
GORESKY C . INITIAL DISTRIBUTION AND RATE OF UPTAKE OF SULFOBROMOPHTHALEIN IN THE LIVER. Am J Physiol. 1964; 207:13-26. DOI: 10.1152/ajplegacy.1964.207.1.13. View

4.
Utili R, Abernathy C, ZIMMERMAN H . Cholestatic effects of Escherichia coli endotoxin endotoxin on the isolated perfused rat liver. Gastroenterology. 1976; 70(2):248-53. View

5.
Heiberg J, Svejgaard E . Toxic hepatis during ketoconazole treatment. Br Med J (Clin Res Ed). 1981; 283(6295):825-6. PMC: 1507043. DOI: 10.1136/bmj.283.6295.825. View